Section Arrow
LNSR.NASDAQ
- LENSAR
Quotes are at least 15-min delayed:2025/04/29 23:57 EDT
Last
 14.05
+0.02 (+0.14%)
Day High 
14.11 
Prev. Close
14.03 
1-M High
14.26 
Volume 
54.51K 
Bid
14
Ask
14.23
Day Low
13.99 
Open
13.99 
1-M Low
13.1248 
Market Cap 
165.42M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 13.81 
20-SMA 13.8 
50-SMA 13.42 
52-W High 17.31 
52-W Low 2.951 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.73/--
Enterprise Value
167.51M
Balance Sheet
Book Value Per Share
0.41
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
53.49M
Operating Revenue Per Share
3.24
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed:2025/04/29 23:57 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.